M Sadelain - JoVE Visualize

Showing results (21-30 of 47) with videos related to

Pageof 5

Sort By:

Gene Therapy|September 24, 2005

Production scale-up and validation of packaging cell clearance of clinical-grade retroviral vector stocks produced in cell factoriesM Przybylowski, A Hakakha, J Stefanski, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 18, 1995

Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin geneM Sadelain, C H Wang, M Antoniou, et al.

Experimental Cell Research|August 31, 2000

Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferationK L MacKenzie, S Franco, C May, et al.

Blood|October 6, 1997

Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacityP Szabolcs, H F Gallardo, D H Ciocon, et al.

Gene|April 21, 2001

Glucose 6-phosphate dehydrogenase expression is less prone to variegation when driven by its own promoterM De Angioletti, A Rovira, R Notaro, et al.

Cancer Metastasis Reviews|June 16, 2000

Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancersM C Gong, S S Chang, M Sadelain, et al.

Nature|July 14, 2000

Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globinC May, S Rivella, J Callegari, et al.

The Journal of Experimental Medicine|August 26, 1998

Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytesA Krause, H F Guo, J B Latouche, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000

Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6F Marti, A Krause, N H Post, et al.

Neoplasia (New York, N.Y.)|August 10, 2000

Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigenM C Gong, J B Latouche, A Krause, et al.

Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:

Pageof 5

Gene Therapy|September 24, 2005

Production scale-up and validation of packaging cell clearance of clinical-grade retroviral vector stocks produced in cell factoriesM Przybylowski, A Hakakha, J Stefanski, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 18, 1995

Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin geneM Sadelain, C H Wang, M Antoniou, et al.

Experimental Cell Research|August 31, 2000

Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferationK L MacKenzie, S Franco, C May, et al.

Blood|October 6, 1997

Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacityP Szabolcs, H F Gallardo, D H Ciocon, et al.

Gene|April 21, 2001

Glucose 6-phosphate dehydrogenase expression is less prone to variegation when driven by its own promoterM De Angioletti, A Rovira, R Notaro, et al.

Cancer Metastasis Reviews|June 16, 2000

Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancersM C Gong, S S Chang, M Sadelain, et al.

Nature|July 14, 2000

Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globinC May, S Rivella, J Callegari, et al.

The Journal of Experimental Medicine|August 26, 1998

Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytesA Krause, H F Guo, J B Latouche, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000

Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6F Marti, A Krause, N H Post, et al.

Neoplasia (New York, N.Y.)|August 10, 2000

Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigenM C Gong, J B Latouche, A Krause, et al.

Pageof 5